UNSPSC 85533881: Destruction of inferior vena cava, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to destruction of inferior vena cava, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06504ZZ

UNSPSC 85533881 Destruction of inferior vena cava, percutaneous endoscopic approach (Commodity) shows minimal alignment with actual state and local procurement activity. The code nominally describes a specific surgical procedure, but recent opportunities tagged under this code represent general medical evaluation, occupational surveillance, pharmacy benefit management, and temporary clinical staffing — none involving the procedure named in the code itself.

The source records no recent state and local solicitations for destruction of inferior vena cava procedures or related vascular interventions. The five opportunities posted between July and September 2026 span the City of Phoenix Retirement Office (disability medical record review and independent medical examinations for pension benefit determinations, RFP RTMRFP26001, due October 16, 2026), the City of Long Beach (surgical benefit carve-out and Center of Excellence network administration for employee health plans, RFP HR26753, due October 7, 2026), the Washington State Department of Transportation on behalf of Washington State Ferries (occupational medical surveillance across 14 ferry locations, RFP RFP20260825, due October 9, 2026), Harris County Juvenile Probation Department (hospital-based emergency and specialty services for detained youth, RFI 071626BNM, due September 25, 2026), Collier County Board of County Commissioners (pharmacy benefit management for county employees and retirees, RFP 25-8414, due April 9, 2026), and the County of Santa Clara Health System (temporary health professional staffing pool across ancillary clinical specialties, RFSQ RFSQHHSFY270052, due October 7, 2026). These opportunities span Arizona, California, Florida, and Washington, but none represent procurement activity matching the code's stated scope. The mismatch suggests either miscoding in the source records or that state and local purchasing does not actively solicit this procedure through standard procurement vehicles.